Addison's disease natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 7: Line 7:


==Natural History==
==Natural History==
If left untreated, Addison's disease can be life-threatening. Any stressful event or illness can cause a sudden worsening of symptoms, which can lead to severe dehydration and fatally low blood pressure and eventually death.
If left untreated, Addison's disease can be life-threatening. Any stressful event or illness can cause a sudden worsening of [[symptoms]], which can lead to severe [[dehydration]] and fatally low [[blood pressure]] and eventually death.


==Complications==
==Complications==
Line 19: Line 19:


==Prognosis==
==Prognosis==
*Prognosis is generally good in patients with Addison's disease as long as they are on life time hormonal therapy.<ref name="pmid19011006">{{cite journal |vauthors=Erichsen MM, Løvås K, Fougner KJ, Svartberg J, Hauge ER, Bollerslev J, Berg JP, Mella B, Husebye ES |title=Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death |journal=Eur. J. Endocrinol. |volume=160 |issue=2 |pages=233–7 |year=2009 |pmid=19011006 |doi=10.1530/EJE-08-0550 |url=}}</ref><ref name="pmid16968806">{{cite journal |vauthors=Bergthorsdottir R, Leonsson-Zachrisson M, Odén A, Johannsson G |title=Premature mortality in patients with Addison's disease: a population-based study |journal=J. Clin. Endocrinol. Metab. |volume=91 |issue=12 |pages=4849–53 |year=2006 |pmid=16968806 |doi=10.1210/jc.2006-0076 |url=}}</ref>
*[[Prognosis]] is generally good in patients with Addison's disease as long as they are on life-time [[hormonal]] therapy.<ref name="pmid19011006">{{cite journal |vauthors=Erichsen MM, Løvås K, Fougner KJ, Svartberg J, Hauge ER, Bollerslev J, Berg JP, Mella B, Husebye ES |title=Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death |journal=Eur. J. Endocrinol. |volume=160 |issue=2 |pages=233–7 |year=2009 |pmid=19011006 |doi=10.1530/EJE-08-0550 |url=}}</ref><ref name="pmid16968806">{{cite journal |vauthors=Bergthorsdottir R, Leonsson-Zachrisson M, Odén A, Johannsson G |title=Premature mortality in patients with Addison's disease: a population-based study |journal=J. Clin. Endocrinol. Metab. |volume=91 |issue=12 |pages=4849–53 |year=2006 |pmid=16968806 |doi=10.1210/jc.2006-0076 |url=}}</ref>
*Patients with Addison's disease must be closely monitored for compliance of medications as acute cases can be life-threating and the mortality rates can go up to 95% in acute crisis settings
*Patients with Addison's disease must be closely monitored for [[Compliance (medicine)|compliance]] with medications as acute cases can be life-threating and the mortality rates can go up to 95% in acute crisis.


==References==
==References==

Revision as of 17:21, 15 September 2017

Addison's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Addison's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Addison's disease natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Addison's disease natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Addison's disease natural history, complications and prognosis

CDC on Addison's disease natural history, complications and prognosis

Addison's disease natural history, complications and prognosis in the news

Blogs on Addison's disease natural history, complications and prognosis

Directions to Hospitals Treating Addison's disease

Risk calculators and risk factors for Addison's disease natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

If left untreated, Addison's disease can be life-threatening. Complications of Addison's disease include hypoglycemia, addisonian crisis, hypoxia, hypovolemic shock, cardiac arrest, stroke. Prognosis is generally good in patients with Addison's disease as long as they are on life time hormonal therapy.

Natural History

If left untreated, Addison's disease can be life-threatening. Any stressful event or illness can cause a sudden worsening of symptoms, which can lead to severe dehydration and fatally low blood pressure and eventually death.

Complications

Complications of Addison's disease include:[1]

Prognosis

  • Prognosis is generally good in patients with Addison's disease as long as they are on life-time hormonal therapy.[2][3]
  • Patients with Addison's disease must be closely monitored for compliance with medications as acute cases can be life-threating and the mortality rates can go up to 95% in acute crisis.

References

  1. Quinkler M (2012). "[Addison's disease]". Med Klin Intensivmed Notfmed (in German). 107 (6): 454–9. doi:10.1007/s00063-012-0112-3. PMID 22907517.
  2. Erichsen MM, Løvås K, Fougner KJ, Svartberg J, Hauge ER, Bollerslev J, Berg JP, Mella B, Husebye ES (2009). "Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death". Eur. J. Endocrinol. 160 (2): 233–7. doi:10.1530/EJE-08-0550. PMID 19011006.
  3. Bergthorsdottir R, Leonsson-Zachrisson M, Odén A, Johannsson G (2006). "Premature mortality in patients with Addison's disease: a population-based study". J. Clin. Endocrinol. Metab. 91 (12): 4849–53. doi:10.1210/jc.2006-0076. PMID 16968806.

Template:WH Template:WS